The International Journal of Cardiac Imaging

, Volume 13, Issue 2, pp 159–160 | Cite as

Editorial comment

  • M. Schwaiger
Article

References

  1. 1.
    Rahimtoola SH. From coronary artery disease to heart failure: role of the hibernating myocardium. Am J Cardiol 1995; 75: 16–22.CrossRefGoogle Scholar
  2. 2.
    Vatner SF. Correlation between acute reductions in myocardial blood flow and function in conscious dogs. Circ Res 1980; 47: 201–7.CrossRefPubMedGoogle Scholar
  3. 3.
    Depré C, Vanoverschelde JLJ, Melin JA et al. Structural and metabolic correlates of the reversibility of chronic left ventricular ischemic dysfunction in humans. Am J Physiol 1995; 268: H1265–H1275.Google Scholar
  4. 4.
    Liedtke AJ. Alterations of carbohydrate and lipid metabolism in acutely ischemic heart. Prog Cardiovasc Dis 1981; 23: 321–36.CrossRefPubMedGoogle Scholar
  5. 5.
    Opie LH. Effects of regional ischemia on metabolism of glucose and fatty acids: relative rates of aerobic and anaerobic energy production during myocardial infarction and comparison with effects of anoxia. Circ Res 1976; 38 (Suppl I): I-51–74.Google Scholar
  6. 6.
    Schelbert HR. Positron Emission Tomography for the assessment of myocardial viability. Circulation 1991; 84 (Suppl I): I-122–131.Google Scholar
  7. 7.
    Schwaiger M, Hicks R. The clinical role of metabolic imaging in the heart by positron emission tomography. J Nucl Med 1991; 32: 565–78.PubMedGoogle Scholar
  8. 8.
    Egert S, Nguyen N, Brosius F et al. Ischemia-induced stimulation of myocardial glucose transport is not inhibited by Wortmannin. Circulation 1996; 94 (Suppl I): 8: I–726.Google Scholar
  9. 9.
    Bax JJ, Visser FC, Van Lingen A, Cornel JH, Fioretti PM, Van der Wall. Metabolic imaging using F18-fluorodeoxyglucose to assess myocardial viability. Int J Cardiac Imag 1997; 13: 145–155.CrossRefGoogle Scholar
  10. 10.
    Eitzmann D, Al-Aouar ZR, Kanter HL et al. Clinical outcome of patients with advanced coronary artery disease after viability studies with positron emission tomography. J Am Coll Cardiol 1992; 10: 559–65.CrossRefGoogle Scholar
  11. 11.
    Tamaki M, Kawamoto M, Takahashi N et al. Prognostic value of an increase in Fluorine-18 deoxyglucose uptake in patients with myocardial infarction: comparison with stress thallium imaging. J Am Coll Cardiol 1993; 22: 1621–7.CrossRefPubMedGoogle Scholar
  12. 12.
    DiCarli M, Davidson M, Little R et al. Value of metabolic imaging with positron emission tomography for evaluating prognosis in patients with coronary artery disease and left ventricular dysfunction. Am J Cardiol 1994; 73: 527–33.CrossRefGoogle Scholar

Copyright information

© Springer Netherlands 1997

Authors and Affiliations

  • M. Schwaiger
    • 1
  1. 1.Nuklearmedizinische Klinik und Poliklinik der TechnischenUniversität MünchenGermany

Personalised recommendations